Meet our doctors Last reviewed: 19 Jun 2026 Sources Effects of once-weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity, Diabetes, Obesity and Metabolism, [accessed 14 January 2026] Transdermal drug delivery: overcoming the skin's barrier function, Europe PMC [accessed 14 January 2026] (D) Routes of delivery: Case studies: (6) Transdermal delivery of peptides and proteins, Advanced Drug Delivery Reviews, [accessed 14 January 2026] Semaglutide for the treatment of overweight and obesity: A review, Diabetes, Obesity and Metabolism, [accessed 14 January 2026] Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK, [accessed 14 January 2026]
Category 1 status means these substances are eligible for compounding by licensed pharmacies under a valid physician prescriptionthe same regulatory framework that governs compounded HRT, dermatology preparations, and other compounded medications
Except for albiglutide, PEG-loxenatide, and mazdutide, all the other 12 GLP-1RAs induced significantly elevated odds ratio of nausea (fig 8C)
Ying, Y
While cravings dont disappear completely for everyone, many people on GLP-1s report a reduced desire to eat sugary, starchy, and high-fat foods
